← Back to Sandu Pharmaceuticals, Inc Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

SANDUPHQPharmaceuticals

Sandu Pharmaceuticals, Inc — Financial Ratios & Key Metrics

₹30.52

-6.58%

P/E Ratio23.53xIndustry: 31.77x

ROE3.75%Return on equity

ROCE5.47%Return on capital

Debt/Equity0.01Low debt

💎

Valuation & Profitability

P/E Ratio

23.53x

Industry Average P/E

31.77x

Dividend Yield

2.02%

Market Cap

₹38.35 (Cr)

Sales Growth 5Y

6.79%

Profit Growth 5Y

16.57%

EPS Growth 5Y

9.55%

OPM 5Y Avg

3.88%

📉

Price Returns

1 Month

-11.33%

3 Months

-17.31%

6 Months

-22.51%

1 Year

-30.64%

52W Low

₹31

Current

₹31

52W High

₹59

0% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹35

▼ Price below SMA 50 — Bearish

SMA 200

₹43

▼ Long-term downtrend

Volume Signal

122% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Sandu Pharmaceuticals, Inc

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.